Clinical Trial Update: Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the estradiol/trimegestone combination for vasomotor symptoms in postmenopausal women has completed. Sponsor Wyeth is now a wholly owne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vasomotor Symptoms

Drugs mentioned

• Estradiol/Trimegestone

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Postmenopause | Phase 4 | Status: COMPLETED